Trials / Completed
CompletedNCT03752437
Comparison of Two Dosages of Heparin Before Extracorporeal Circulation
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Astes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study the investigators will study two dosages of heparin before extracorporeal circulation in open chest cardiac surgery.
Detailed description
In this study the investigators will study two dosages of heparin before extracorporeal circulation in open chest cardiac surgery. The first dosage will be 300 IU per kilogram of REAL weight, the second dosage will be 300 IU per kilogram of IDEAL weight.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | ACT (Activated Clotting Time) | Measure of ACT in the two arms in order to determine if injection of heparin based on ideal weight is better or not than those one on real weight. |
| DRUG | Heparin | 300 IU of heparin |
Timeline
- Start date
- 2019-10-01
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
- First posted
- 2018-11-26
- Last updated
- 2022-02-15
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03752437. Inclusion in this directory is not an endorsement.